Julieanne G. McGregor

Julieanne G. McGregor

Integrative Medicine | Internal Medicine

5915 Farrington Rd
Ste 106
Chapel Hill, NC 27517

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS.

Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: December 10, 2015

Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis.

Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: March 26, 2015

Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function.

Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: March 26, 2015

What Everybody is Doing but No One is Talking About: Use of Complementary and Alternative Medicine in the ANCA Associated Vasculitis Population.

What Everybody is Doing but No One is Talking About: Use of Complementary and Alternative Medicine in the ANCA Associated Vasculitis Population.

Journal: Journal of autoimmune diseases and rheumatology

Published: January 20, 2015

Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies.

Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies.

Journal: Clinical and experimental immunology

Published: November 05, 2014

Gleaning relapse risk from B cell phenotype: decreased CD5+ B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitis.

Gleaning relapse risk from B cell phenotype: decreased CD5+ B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitis.

Journal: Annals of the rheumatic diseases

Published: October 08, 2014

Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure.

Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: March 01, 2014

Decreased CD5⁺ B cells in active ANCA vasculitis and relapse after rituximab.

Decreased CD5⁺ B cells in active ANCA vasculitis and relapse after rituximab.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: January 08, 2013

Pathways to renal biopsy and diagnosis among patients with ANCA small-vessel vasculitis.

Pathways to renal biopsy and diagnosis among patients with ANCA small-vessel vasculitis.

Journal: Clinical and experimental rheumatology

Published: September 17, 2012

Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis.

Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis.

Journal: The Journal of clinical investigation

Published: July 12, 2012

Vasculitis: the elusive optimal induction strategy for vasculitis.

Vasculitis: the elusive optimal induction strategy for vasculitis.

Journal: Nature reviews. Nephrology

Published: February 08, 2012

Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease.

Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: December 03, 2011

Showing 1-12 of 13

Last Updated: 09/26/2026